Senators Push Bill to Legalize Medical Cannabis for Veterans
Two U.S. Senators introduced legislation that would allow doctors at the VA to prescribe medical cannabis to veterans in the 31 states that have established medical-marijuana programs.
Two U.S. Senators introduced legislation on Wednesday, September 5, 2018, that would allow doctors at the U.S. Department of Veterans Affairs (VA) to prescribe medical cannabis to veterans in the 31 states that have established medical-marijuana programs. The legislation was sponsored by Senators Bill Nelson (D-FL) and Brian Schatz (D-HI).
According to a press release from Senator Nelson, the bill would create a temporary, five-year safe harbor protection for veterans who use medical cannabis. The bill would also direct the VA to conduct research on the effects of medical cannabis on veterans who are in pain and how prescribing cannabis to veterans can be used to reduce opioid abuse. Veterans are currently twice as likely as civilians to die from opioid overdose.
“Federal law prohibits VA doctors from prescribing or recommending medical marijuana to veterans,” Nelson said in the press release. “This legislation will allow veterans in Florida and elsewhere the same access to legitimately prescribed medication, just as any other patient in those 31 states would have.”
For more information or to view a copy of the bill, please visit the press release link below.
References:
Medical Cannabis Campaigning with Americans for Safe Access
September 4th 2024As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
